tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Aptose Biosciences (APTO) and Applied Molecular Transport (AMTI)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aptose Biosciences (APTOResearch Report) and Applied Molecular Transport (AMTIResearch Report) with bullish sentiments.

Aptose Biosciences (APTO)

In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Aptose Biosciences, with a price target of $6.00. The company’s shares closed last Tuesday at $1.10, close to its 52-week low of $1.00.

According to TipRanks.com, Renza is ranked 0 out of 5 stars with an average return of -11.0% and a 24.5% success rate. Renza covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Verrica Pharmaceuticals, and Pacira Pharmaceuticals.

Aptose Biosciences has an analyst consensus of Strong Buy, with a price target consensus of $8.43, implying a 652.7% upside from current levels. In a report issued on April 28, Cantor Fitzgerald also initiated coverage with a Buy rating on the stock with a $10.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Applied Molecular Transport (AMTI)

In a report released today, Joseph Schwartz from SVB Securities maintained a Buy rating on Applied Molecular Transport, with a price target of $60.00. The company’s shares closed last Tuesday at $4.26, close to its 52-week low of $3.63.

According to TipRanks.com, Schwartz is ranked 0 out of 5 stars with an average return of -17.9% and a 23.0% success rate. Schwartz covers the Healthcare sector, focusing on stocks such as Mereo Biopharma Group Plc, Crinetics Pharmaceuticals, and Ultragenyx Pharmaceutical.

Currently, the analyst consensus on Applied Molecular Transport is a Strong Buy with an average price target of $65.00, a 1387.4% upside from current levels. In a report issued on April 26, Bank of America Securities also maintained a Buy rating on the stock with a $49.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on APTO:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed